Skip to content

Clinical trials

Terminated Prostatic Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Status: Terminated Country / region: United Kingdom Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20063
20083
20094
20102
20123
20132
20141
20152
20162
20183
20193
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ferring Pharmaceuticals3
Astellas Pharma Inc2
Cell Genesys2
Ipsen2
Sanofi2
Advanced Medical Diagnostics s.a.1
Astex Pharmaceuticals, Inc.1
AstraZeneca1
BioNTech SE1
Bracco Diagnostics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms36
Neoplasms4
Neoplasm Metastasis3
Carcinoma, Non-Small-Cell Lung2
Adenocarcinoma1
Breast Neoplasms1
Bulbo-Spinal Atrophy, X-Linked1
Endometrial Neoplasms1
Esophageal Squamous Cell Carcinoma1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.